Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Performance of [68Ga]Ga-OncoACP3 PET Imaging in Prostate Cancer
NCT07830212Phase 2Not yet recruiting
- Sponsor
- Yonghe Medical
- Start
- Oct 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-Onco-ACP3 in prostate cancer (PCa), sponsored by Yonghe Medical. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
68Ga-Onco-ACP3
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07830212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07830212.